Towards commercial production of sponge medicines
- PMID: 20098610
- PMCID: PMC2810229
- DOI: 10.3390/md7040787
Towards commercial production of sponge medicines
Abstract
Sponges can provide potential drugs against many major world-wide occurring diseases. Despite the high potential of sponge derived drugs no sustainable production method has been developed. Thus far it is not fully understood why, when, where and how these metabolites are produced in sponges. For the near future sea-based sponge culture seems to be the best production method. However, for controlled production in a defined system it is better to develop in vitro production methods, like in vitro sponge culture or even better sponge cell culture, culture methods for symbionts or the transfer of production routes into another host. We still have insufficient information about the background of metabolite production in sponges. Before production methods are developed we should first focus on factors that can induce metabolite production. This could be done in the natural habitat by studying the relation between stress factors (such as predation) and the production of bioactive metabolites. The location of production within the sponge should be identified in order to choose between sponge cell culture and symbiont culture. Alternatively the biosynthetic pathways could be introduced into hosts that can be cultured. For this the biosynthetic pathway of metabolite production should be unraveled, as well as the genes involved. This review discusses the current state of sponge metabolite production and the steps that need to be taken to develop commercial production techniques. The different possible production techniques are also discussed.
Keywords: bioactive metabolite; biosynthetic pathway; cell culture; sponge culture; sponge medicine.
Figures




Similar articles
-
Sustainable use of marine resources: cultivation of sponges.Prog Mol Subcell Biol. 2003;37:143-62. doi: 10.1007/978-3-642-55519-0_6. Prog Mol Subcell Biol. 2003. PMID: 15825643 Review.
-
Producing drugs from marine sponges.Biotechnol Adv. 2003 Oct;21(7):585-98. doi: 10.1016/s0734-9750(03)00100-9. Biotechnol Adv. 2003. PMID: 14516872 Review.
-
Sustainable production of bioactive compounds from sponges: primmorphs as bioreactors.Prog Mol Subcell Biol. 2003;37:163-97. doi: 10.1007/978-3-642-55519-0_7. Prog Mol Subcell Biol. 2003. PMID: 15825644 Review.
-
Large-scale production of pharmaceuticals by marine sponges: sea, cell, or synthesis?Biotechnol Bioeng. 2005 Apr 20;90(2):201-22. doi: 10.1002/bit.20404. Biotechnol Bioeng. 2005. PMID: 15739169
-
Cultivation of sponges, sponge cells and symbionts: achievements and future prospects.Adv Mar Biol. 2012;62:273-337. doi: 10.1016/B978-0-12-394283-8.00006-0. Adv Mar Biol. 2012. PMID: 22664125
Cited by
-
Sources of secondary metabolite variation in Dysidea avara (Porifera: Demospongiae): the importance of having good neighbors.Mar Drugs. 2013 Feb 18;11(2):489-503. doi: 10.3390/md11020489. Mar Drugs. 2013. PMID: 23429282 Free PMC article.
-
Application of diffusion growth chambers for the cultivation of marine sponge-associated bacteria.Mar Biotechnol (NY). 2014 Oct;16(5):594-603. doi: 10.1007/s10126-014-9575-y. Epub 2014 May 17. Mar Biotechnol (NY). 2014. PMID: 24838766
-
Anti-biofilm compounds derived from marine sponges.Mar Drugs. 2011;9(10):2010-2035. doi: 10.3390/md9102010. Epub 2011 Oct 19. Mar Drugs. 2011. PMID: 22073007 Free PMC article. Review.
-
A Soft Spot for Chemistry-Current Taxonomic and Evolutionary Implications of Sponge Secondary Metabolite Distribution.Mar Drugs. 2021 Aug 4;19(8):448. doi: 10.3390/md19080448. Mar Drugs. 2021. PMID: 34436287 Free PMC article. Review.
-
Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives.Mar Drugs. 2014 Aug 19;12(8):4539-77. doi: 10.3390/md12084539. Mar Drugs. 2014. PMID: 25196730 Free PMC article. Review.
References
-
- Faulkner DJ. Marine natural products. Nat Prod Rep. 2002;19:1–48. - PubMed
-
- Dumdei EJ, Blunt JW, Munro MHG, Battershill CN, Page MJ. In: The Whys and Whats of Sponge Chemistry: Why Chemists Extract Sponges and What Problems Does This Cause? Watanabe Y, Fusetani N, editors. Springer-Verlag; Tokyo, Japan: 1998. pp. 353–364.
-
- Sipkema D, Osinga R, Schatton W, Mendola D, Tramper J, Wijffels RH. Large-scale production of pharmaceuticals by marine sponges: Sea, cell, or synthesis. Biotechnol Bioeng. 2005;90:201–222. - PubMed
-
- Hoover CA, Slattery M, Marsh AG. A functional approach to transcriptome profiling: Linking gene expression patterns to metabolites that matter. Mar Biotechnol. 2007;9:411–419. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical